Veterinary Oncology Market Reach To US$ 909.4 Million by 2026 | Key Players Growth Analysis, Clinical Assessment and Professional Business Outlook 2020

Global Veterinary Oncology Market

Veterinary cancer therapies aim to permanently eradicate the cancerous cells prevalent in pets. The veterinarian recommends specific treatments such as targeted therapy and combination therapy or chemotherapy depending on the type of cancer, stage, and nature of the cancer. The ongoing research activities undertaken by researchers for the development of novel formulations and therapies is expected to accelerate the global veterinary oncology market growth. For instance, in 2015 researchers at the University of Veterinary Medicine Vienna are exploring the molecular basis of cancer progression in canine cell lines. The research states that the modern cancer therapy can be revolutionized with the introduction of targeted therapies.

The global veterinary oncology market was evaluated at US$ 401.8 million in 2018, and is expected to witness a 10.9% CAGR over the forecast period (2019-2026).

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/2995

Global Veterinary Oncology Market Share (%) Analysis, By Animal Type, 2018

Source: Coherent Market Insights Analysis (2019)

Increasing R&D initiatives and veterinary healthcare expenditure for cancer management to accelerate the global veterinary oncology market development

Increasing number of research grants for the launch various anti-cancer therapies for veterinary cancer treatments is a major factor driving the growth of the global veterinary oncology market. For instance, in 2017, Animal Cancer Foundation (ACF) received a US$ 1 million grant from the Blue Buffalo Foundation to support comparative oncology research to study similarities between naturally occurring cancers in people and pets and find effective treatment for both species.

Growing expenditure on animal healthcare due to increasing pet healthcare spending by pet owners, especially in the developed economies is another major factor driving the veterinary oncology market growth. For instance, according to the American Pet Products Association report released in March 2018, the overall spending in the U.S. veterinary care increased by 4.1% between 2016 and 2017, from US$ 66.75 billion to US$ 69.51 billion which is expected to bring development in animal treatment.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2995

Global Veterinary Oncology Market Restraints

High costs associated with chemotherapies, immunotherapies, and targeted therapies, is a significant aspect restraining the global veterinary oncology market growth. According to a study conducted by the University of Wisconsin, in 2015, the initial veterinary cancer diagnosis costs ranged from US$ 1,000 to US$ 2,000, while the cost of a standard course of chemotherapy ranged from US$ 3,000 to US$ 5,000, depending on the type and severity of cancer.

Global Veterinary Oncology Market – Regional Insights

North America is expected to hold a dominant position in the global veterinary oncology market over the forecast timeframe, owing to the rising focus of key market players of the region on adopting strategies, such as partnership and acquisitions, to expand their product portfolio. For instance, in April 2019, Elanco Animal Health signed an agreement to acquire Aratana Therapeutics, a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats in the U.S.

Asia Pacific is expected to witness a rapid growth in the global veterinary oncology market during the forecast period, owing to the presence of various veterinary foundations focusing on veterinary cancer research. For instance, the Australian Animal Cancer Foundation, Australia supports scientific research on veterinary cancer and seeks funds from government and private organizations. The foundation also supports Australian Comparative Oncology Consortium, consisting of Australian veterinary oncology specialists who collaborate to develop novel therapies. Moreover, a high prevalence of cancer among dogs is also expected to boost the market growth in the region. According to the Australia Canine Center, cancer affects one out of every three dogs during their lifetimes.

Global Veterinary Oncology Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2026

Source: Coherent Market Insights Analysis (2019)

Global Veterinary Oncology Market – Competitive Background

The most prominent players operating in the global veterinary oncology market include Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., and Rhizen Pharmaceutical SA.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/veterinary-oncology-market-to-surpass-us-9094-million-by-2026-2460

Detailed Segmentation:

• Global Veterinary Oncology Market, By Animal Type:
  • Companion Animal
    • Equine
    • Canine
    • Feline
  • Livestock Animal
• Global Veterinary Oncology Market, By Therapy Type:
  • Chemotherapy
  • Combination Therapy
  • Immunotherapy
  • Targeted Therapy
• Global Veterinary Oncology Market, By Mode of Administration:
  • Oral
  • Intravenous
• Global Veterinary Oncology Market, By Application:
  • Canine Lymphoma
  • Osteosarcoma (OSA)
  • Mast Cell Cancer
  • Melanoma
  • Multiple Myeloma
• Global Veterinary Oncology Market, By Distribution Channel:
  • Hospital Pharmacies
  • Government Agencies
  • Retail Pharmacies

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.